TweetFullerenes used to make better, more stable MRI imaging agent. Investigators from the National Cancer Institute’s Cancer Nanotechnology Platform Partnership at Virginia Commonwealth University have developed a new imaging agent that is 40 times more potent at boosting magnetic resonance imaging (MRI) signals than agents currently approved for human clinical use.
Editor/Authors are :
Brian Wang, Director of Research.
Sander Olson, Interviews and other articles
Phil Wolff, Communications and social technologist.
Alvin Wang. Computer, technology, social networking, and social media expert.